Innovative Medicines Canada/Médicaments novateurs Canada
Occurred:
2024-10-16
Details Regarding the Identified Subject Matter
|
Subject matters
|
Details
|
Environment, Foreign Affairs, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
|
Activities related to the Convention on Biological Diversity (CBD) including Digital Sequence Information (DSI) and an Access and Benefit Sharing (ABS) framework.
|
